(Q63841322)
Statements
Double Blind, Randomised, Parallel Group, Placebo Controlled Trial of a Combination of THC and CBD in Patients With Multiple Sclerosis, Followed by an Open Label Assessment and Study Extension (English)
0 references
May 2001
0 references
July 2002
0 references
160
0 references
18 year
0 references